Compare Datadog Inc (DDOG) vs Royalty Pharma plc Class A Ordinary Shares (RPRX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Datadog Inc vs Royalty Pharma plc Class A Ordinary Shares — how do they compare? Datadog Inc trades at $270.4 (market cap $97.43B), while Royalty Pharma plc Class A Ordinary Shares trades at $56.2 (market cap $25.27B). The key difference: Datadog Inc is far larger — about 3.9× Royalty Pharma plc Class A Ordinary Shares's market cap, and Royalty Pharma plc Class A Ordinary Shares pays a 1.66% dividend while Datadog Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Datadog Inc for 76 Days and Royalty Pharma plc Class A Ordinary Shares for 0 Days on average.
| DDOG | RPRX | |
|---|---|---|
Market Cap | $97.43B | $25.27B |
Volume | 1,586,926 | 3,671,183 |
Sector | Technology | Health |
52-Week High | $288.15 | $63.96 |
52-Week Low | $102.62 | $35.44 |
Typical Hold Time | 76 Days | 0 Days |
Enterprise Value | $93.72B | $32.50B |
Dividend Yield | — | 1.66% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Datadog (DDOG) trades at $273.8, down 1.6% on the day, yet maintains a bullish technical stance with strong analyst support. The stock has consistently beaten earnings estimates in recent quarters, with Q3 2026 results pending. Revenue growth remains robust, climbing from $1.7B in 2022 to $3.4B in 2025, though net income margins are volatile. Positive sentiment is fueled by AI-driven demand and global expansion, as highlighted in recent financial media.
The outlook is cautiously optimistic given high valuation multiples (P/E 542.68) and negative net cash flow, but strong revenue growth and a dominant buy rating consensus (83.34%) suggest upside to the $276.10 price target. Key risks include competitive pressures and reliance on enterprise cloud spending cycles.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Datadog Inc
Datadog is a cloud-native company that focuses on analyzing machine data. The firm's product portfolio, delivered as software-as-a-service, allows a client to monitor and analyze its entire IT infrastructure. Datadog's platform can ingest and analyze large amounts of machine-generated data in real time, allowing clients to utilize it for a variety of different applications throughout their businesses.
Read more on DDOG →About Royalty Pharma plc Class A Ordinary Shares
Royalty Pharma acquires interests in royalties from biopharmaceutical products. Its model gives it exposure to medicines developed and sold by other life sciences companies.
Read more on RPRX →
